Literature DB >> 15293578

False-positive plasma (1-->3)-beta-D-glucan test following immunoglobulin product replacement in an adult bone marrow recipient.

Masahiro Ogawa, Hiroki Hori, Shigeko Niiguchi, Eiichi Azuma, Yoshihiro Komada.   

Abstract

Mesh：

Substances：

Year:  2004        PMID： 15293578     DOI： 10.1532/ijh97.04030

Source DB:  PubMed          Journal:  Int J Hematol        ISSN： 0925-5710            Impact factor:   2.490


× No keyword cloud information.
  6 in total

1.  [Investigation of the influence of hemodialysis membranes and factors associated with hemodialysis on serum (1-->3)-beta-D-glucan].

Authors:  K Yoshida; M Nakajima; M Yamasaki; Y Kitano; Y Niki; G Ohsawa; T Matsushima
Journal:  Kansenshogaku Zasshi       Date:  1998-03

2.  False-positive result in Limulus test caused by Limulus amebocyte lysate-reactive material in immunoglobulin products.

Authors:  K Ikemura; K Ikegami; T Shimazu; T Yoshioka; T Sugimoto
Journal:  J Clin Microbiol       Date:  1989-09       Impact factor: 5.948

3.  Positive (1-->3)-beta-D-glucan in blood components and release of (1-->3)-beta-D-glucan from depth-type membrane filters for blood processing.

Authors:  Makoto Usami; Atsushi Ohata; Takeshi Horiuchi; Koichi Nagasawa; Toshio Wakabayashi; Shigenori Tanaka
Journal:  Transfusion       Date:  2002-09       Impact factor: 3.157

4.  Inactivation of a particle beta-glucan by proteins in plasma and serum.

Authors:  T Miura; N Ohno; N N Miura; S Shimada; T Yadomae
Journal:  Biol Pharm Bull       Date:  1997-10       Impact factor: 2.233

5.  A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation.

Authors:  J L Goodman; D J Winston; R A Greenfield; P H Chandrasekar; B Fox; H Kaizer; R K Shadduck; T C Shea; P Stiff; D J Friedman
Journal:  N Engl J Med       Date:  1992-03-26       Impact factor: 91.245

6.  Plasma (1-->3)-beta-D-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes.

Authors:  T Obayashi; M Yoshida; T Mori; H Goto; A Yasuoka; H Iwasaki; H Teshima; S Kohno; A Horiuchi; A Ito
Journal:  Lancet       Date:  1995-01-07       Impact factor: 79.321
  6 in total
  14 in total

1.  Evaluation of serum (1 → 3)-β-D-glucan clinical performance: kinetic assessment, comparison with galactomannan and evaluation of confounding factors.

Authors:  P Pini; C Bettua; C F Orsi; C Venturelli; F Forghieri; S Bigliardi; L Faglioni; F Luppi; L Serio; M Codeluppi; M Luppi; C Mussini; M Girardis; Elisabetta Blasi
Journal:  Infection       Date:  2015-10-16       Impact factor: 3.553

2.  How to interpret serum levels of beta-glucan for the diagnosis of invasive fungal infections in adult high-risk hematology patients: optimal cut-off levels and confounding factors.

Authors:  H Hammarström; N Kondori; V Friman; C Wennerås
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-01-09       Impact factor: 3.267

3.  Efficacy of Cerebrospinal Fluid Beta-d-Glucan Diagnostic Testing for Fungal Meningitis: a Systematic Review.

Authors:  Christian Davis; L Joseph Wheat; Thein Myint; David R Boulware; Nathan C Bahr
Journal:  J Clin Microbiol       Date:  2020-03-25       Impact factor: 5.948

4.  Usefulness of 1,3 Beta-D-Glucan Detection in non-HIV Immunocompromised Mechanical Ventilated Critically Ill Patients with ARDS and Suspected Pneumocystis jirovecii Pneumonia.

Authors:  Tobias Lahmer; Clarissa Prazeres da Costa; Jürgen Held; Sebastian Rasch; Ursula Ehmer; Roland M Schmid; Wolfgang Huber
Journal:  Mycopathologia       Date:  2017-04-04       Impact factor: 2.574

5.  Blood (1->3)-beta-D-glucan as a diagnostic test for HIV-related Pneumocystis jirovecii pneumonia.

Authors:  Paul E Sax; Lauren Komarow; Malcolm A Finkelman; Philip M Grant; Janet Andersen; Eileen Scully; William G Powderly; Andrew R Zolopa
Journal:  Clin Infect Dis       Date:  2011-07-15       Impact factor: 9.079

6.  Reactivity of (1-->3)-beta-d-glucan assay with commonly used intravenous antimicrobials.

Authors:  Francisco M Marty; Colleen M Lowry; Steven J Lempitski; David W Kubiak; Malcolm A Finkelman; Lindsey R Baden
Journal:  Antimicrob Agents Chemother       Date:  2006-10       Impact factor: 5.191

7.  (1,3)-β-d-glucan in cerebrospinal fluid for diagnosis of fungal meningitis associated with contaminated methylprednisolone injections.

Authors:  Anurag N Malani; Bonita Singal; L Joseph Wheat; Ola Al Sous; Theresa A Summons; Michelle M Durkin; April C Pettit
Journal:  J Clin Microbiol       Date:  2014-12-24       Impact factor: 5.948

Review 8.  Invasive pulmonary aspergillosis: current diagnostic methodologies and a new molecular approach.

Authors:  S Moura; L Cerqueira; A Almeida
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-05-13       Impact factor: 3.267

9.  Challenges with Utilizing the 1,3-Beta-d-Glucan and Galactomannan Assays To Diagnose Invasive Mold Infections in Immunocompromised Children.

Authors:  Alice J Hsu; Pranita D Tamma; Sean X Zhang
Journal:  J Clin Microbiol       Date:  2021-08-18       Impact factor: 5.948

10.  Development of a Highly Sensitive β-Glucan Detection System Using Scanning Single-Molecule Counting Method.

Authors:  Yoshiyuki Adachi; Hidetaka Nakata; Tetsuya Tanabe; Daisuke Yamanaka; Takashi Kanno; Ken-Ichi Ishibashi; Naohito Ohno
Journal:  Int J Mol Sci       Date:  2021-06-01       Impact factor: 5.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.